Endothelial dysfunction during long-term follow-up in children with STEC hemolyticuremic syndrome.
Kreuzer M, Sollmann L, Ruben S, Leifheit-Nestler M, Fischer DC, Pape L, Haffner D
Pediatr Nephrol. 2017 Feb 8. doi: 10.1007/s00467-016-3574-3

Belatacept after kidney transplantation in adolescents: a retrospective study.
Lerch C, Kanzelmeyer NK, Ahlenstiel-Grunow T, Froede K, Kreuzer M, Drube J, Verboom M, Pape L
Transpl Int. 2017 Feb 6. doi: 10.1111/tri.12932

Switching from immediate- to extended-release cysteamine in nephropathic cystinosis patients: a retrospective real-life single-center study.
Ahlenstiel-Grunow T, Kanzelmeyer NK, Froede K, Kreuzer M, Drube J, Lerch C, Pape L.
Pediatr Nephrol. 2016 Jun 27.

Transitional Care and Adherence of Adolescents and Young Adults After Kidney Transplantation in Germany and Austria: A Binational Observatory Census Within the TRANSNephro Trial.
Kreuzer M*, Prüfe J, Oldhafer M, Bethe D, Dierks ML, Müther S, Thumfart J, Hoppe B, Büscher A, Rascher W, Hansen M, Pohl M, Kemper MJ, Drube J, Rieger S, John U, Taylan C, Dittrich K, Hollenbach S, Klaus G, Fehrenbach H, Kranz B, Montoya C, Lange-Sperandio B, Ruckenbrodt B, Billing H, Staude H, Heindl-Rusai K, Brunkhorst R, Pape L.
Medicine (Baltimore). 2015 Dec;94(48):e2196

Whole-exome sequencing identifies mutations of TBC1D1 encoding a Rab-GTPase-activating protein in patients with congenital anomalies of the kidneys and urinary tract (CAKUT).
Kosfeld A**, Kreuzer M**, Daniel C, Brand F, Schäfer AK, Chadt A, Weiss AC, Riehmer V, Jeanpierre C, Klintschar M, Bräsen JH, Amann K, Pape L, Kispert A, Al-Hasani H, Haffner D, Weber RG
Hum Genet. 2015 Nov 16. [Epub ahead of print]

Dialysis-dependent acute kidney injury in children with end-stage liver disease: prevalence, dialysis modalities and outcome.
Kreuzer M*, Gähler D, Rakenius AC, Prüfe J, Jack T, Pfister ED, Pape L.
Pediatr Nephrol. 2015 Aug 1

The TRANSNephro-study examining a new transition model for post-kidney transplant adolescents and an analysis of the present health care: study protocol for a randomized controlled trial
Kreuzer M*, Prüfe J, Bethe D, Vogel Ch, Großhennig A, Koch A, Oldhafer M, Dierks M-L, Albrecht U-V, Müther S, Brunkhorst R, Pape L.
Trials 2014, 15:505 23 December 2014

Correlations with six-month protocol biopsy findings in pediatric transplant recipients on low- and regular-dose CNI regimens.
Kanzelmeyer NK, Ahlenstiel T, Kreuzer M, Becker JU, Pape L.
Clin Transplant. 2013 Mar-Apr;27(2):319-23

Course of immunization titers after pediatric kidney transplantation and association with glomerular filtration rate and kidney function.
Beil S**, Kreuzer M**, Pape L.
Transplantation. 2012 Dec 15;94(11):e69-71

An outbreak of Shiga toxin-producing Escherichia coli O104:H4 hemolytic uremic syndrome in Germany: presentation and short-term outcome in children.
Loos S, Ahlenstiel T, Kranz B, Staude H, Pape L, Härtel C, Vester U, Buchtala L, Benz K, Hoppe B, Beringer O, Krause M, Müller D, Pohl M, Lemke J, Hillebrand G, Kreuzer M, König J, Wigger M, Konrad M, Haffner D, Oh J, Kemper MJ.
Clin Infect Dis. 2012 Sep;55(6):753-9.

The influence of low donor age, living related donation and pre-emptive transplantation on end-organ damage based on arterial hypertension after paediatric kidney transplantation.
Heidotting NA, Ahlenstiel T, Kreuzer M, Franke D, Pape L.
Nephrol Dial Transplant. 2011 Oct 10. [Epub ahead of print]

Regional citrate anticoagulation-a safe and effective procedure in pediatric apheresis therapy.
Kreuzer M*, Ahlenstiel T, Kanzelmeyer N, Ehrich JH, Pape L.
Pediatr Nephrol. 2011 Jan;26(1):127-32. Epub 2010 Oct 21.

Protocol biopsy-driven interventions after pediatric renal transplantation.
Kanzelmeyer NK, Ahlenstiel T, Drube J, Froede K, Kreuzer M, Broecker V, Ehrich JH, Melk A, Pape L.
Pediatr Transplant. 2010 Dec;14(8):1012-8. doi: 10.1111/j.1399-3046.2010.01399.x. Epub 2010 Sep 15.

De novo therapy with everolimus, low-dose ciclosporine A, basiliximab and steroid elimination in pediatric kidney transplantation.
Pape L, Offner G, Kreuzer M, Froede K, Drube J, Kanzelmeyer N, Ehrich JH, Ahlenstiel T.
Am J Transplant. 2010 Oct;10(10):2349-54. doi: 10.1111/j.1600-6143.2010.03266.x. Epub 2010 Sep 14.

Regional citrate anticoagulation is safe in intermittent high-flux haemodialysis treatment of children and adolescents with an increased risk of bleeding.
Kreuzer M*, Bonzel KE, Büscher R, Offner G, Ehrich JH, Pape L.
Nephrol Dial Transplant. 2010 Oct;25(10):3337-42. Epub 2010 Apr 26.

Management of regional citrate anticoagulation in pediatric high-flux dialysis: activated coagulation time versus post-filter ionized calcium.
Kreuzer M*, Ahlenstiel T, Kanzelmeyer N, Ehrich JH, Pape L.
Pediatr Nephrol. 2010 Jul;25(7):1305-10. Epub 2010 Mar 11.

Haemorrhagic complications in paediatric dialysis-dependent acute kidney injury: Incidence and impact on outcome.
Kreuzer M*, Ehrich JH, Pape L.
Nephrol Dial Transplant. 2010 Apr;25(4):1140-6. Epub 2009 Nov 13.

Early erythropoietin reduced the need for red blood cell transfusion in childhood hemolytic uremic syndrome: a randomized prospective pilot trial.
Pape L, Ahlenstiel T, Kreuzer M, Drube J, Froede K, Franke D, Ehrich JH, Haubitz M.
Pediatr Nephrol. 2009 May;24(5):1061-4. Epub 2008 Dec 16.

Improved gastrointestinal symptom burden after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in kidney transplanted children.
Pape L, Ahlenstiel T, Kreuzer M, Ehrich JH.
Pediatr Transplant. 2008 Sep;12(6):640-2.

Kinetic Studies on Urea Extraction with Hemodialysis in Adolescents by On-line Monitoring of Dialysate Urea.
Kreuzer M, Drossert T, Stein A, Arbeiter A, Vester U, Bonzel K-E.
Hemodial Int 2004, 8 (1): 107